KBIO LABS Inc.

KOSDAQ:A038530 Stock Report

Market Cap: ₩25.8b

KBIO LABS Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

JungYoung Cho

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Analysis Article • Feb 04

KBIO COMPANY Inc. (KOSDAQ:038530) Held Back By Insufficient Growth Even After Shares Climb 56%

KBIO COMPANY Inc. ( KOSDAQ:038530 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Nov 21

Not Many Are Piling Into KBIO COMPANY Inc. (KOSDAQ:038530) Just Yet

With a price-to-sales (or "P/S") ratio of 0.3x KBIO COMPANY Inc. ( KOSDAQ:038530 ) may be sending bullish signals at...
Analysis Article • Apr 08

Here's Why We're Not At All Concerned With KBIO's (KOSDAQ:038530) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Analysis Article • Jan 08

Market Might Still Lack Some Conviction On KBIO COMPANY Inc. (KOSDAQ:038530) Even After 38% Share Price Boost

KBIO COMPANY Inc. ( KOSDAQ:038530 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Nov 22

We Think KBIO's (KOSDAQ:038530) Robust Earnings Are Conservative

KBIO COMPANY Inc. ( KOSDAQ:038530 ) recently posted some strong earnings, and the market responded positively. We did...
Analysis Article • Jul 16

KBIO (KOSDAQ:038530) Is In A Strong Position To Grow Its Business

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article • Mar 27

We're Not Worried About KBIO's (KOSDAQ:038530) Cash Burn

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

CEO

JungYoung Cho (65 yo)

no data
Tenure

Mr. JungYoung Cho serves as CEO & Director of KBIO LABS Inc.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/14 20:06
End of Day Share Price 2026/08/26 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

KBIO LABS Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.